CD276 and central nervous system cancer: A recent study discovered that the immune-checkpoint proteins CD276, programmed cell death ligand (PD-L) 1, and PD-L2 were expressed by the TAMs that engulfed the glioma cells and that this led the TAMs to become M2-like that drove immunosuppression by inhibiting the growth of activated T cells [34].